NCT05336877 - Aveir VR Coverage With Evidence Development Post-Approval Study | Biotech Hunter

Enrollment

8,744

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions

Cardiac PacemakerArrythmiaBradycardia

Interventions

DEVICE

Aveir VR Leadless Pacemaker System

This study will utilize real-world data from patients implanted with the Aveir VR Leadless Pacemaker System. No device intervention is required in this study.

DEVICE

Single-Chamber Transvenous Pacemaker

This study will utilize real-world data from patients implanted with a single-chamber transvenous pacemaker as a comparator to the Aveir VR LP system study arm. No device intervention is required in this study.

Trial Locations (1)

91342

RECRUITING

Abbott, Sylmar